New COVID-19 lockdowns imperil global economy’s recovery

A significant chunk of the worldwide restoration in firms’ earnings – restoration anticipated within the first quarter of 2021 – is liable to being pushed again additional as coronavirus lockdowns and mobility restrictions in a number of international locations cloud hopes of a swifter financial rebound, funding banks mentioned.

China introduced lockdowns in 4 cities and European international locations unveiled tighter and longer coronavirus restrictions on Wednesday, denting back-to-normal hopes and sparking worries about additional financial injury in 2021.

Germany, the UK and the Netherlands indicated strict COVID-19 curbs would final into early February, and Italy mentioned it could prolong its state of emergency to the tip of April. Japan additionally expanded a state of emergency in Tokyo, hurting the prospects of holding an already-delayed Summer time Olympic Video games.

In america, sweeping stay-at-home orders had been reinstituted final month in California, probably the most populous state, as infections surged.

These actions globally prompted phrases of warning from main funding banks and different market watchers.

“A further wave of COVID is among the many key dangers to be monitored this 12 months,” mentioned Vincent Manuel, world CIO at Indosuez Wealth Administration.

“Up to now two quarters, we had been within the development of optimistic earnings momentum each in Europe and within the US, which was coming from the worth segments of the market. Now it’s true that ought to we’ve disruptions from COVID, it could set off detrimental revisions for Q1, however what issues, much more, is the rebound capability of earnings over the next quarters.”

Analysts’ earnings estimates for the primary quarter didn’t replicate the fear, both. Europe is seen reporting a whopping 40 % leap in earnings, whereas earnings of US S&P 500 firms are forecast to rise by 16 %, based on IBES information from Refinitiv. The S&P 500 first-quarter estimated revenue progress is up barely since January 1.

First-quarter and 2021 company steering will probably be key for buyers within the coming weeks. This week marks the beginning of fourth-quarter 2020 earnings for US firms, with outcomes from JPMorgan Chase and different main banks due on Friday.

“We see dangers of downward steering this earnings season,” Financial institution of America Fairness Strategist Savita Subramanian mentioned in a word on Wednesday, highlighting a consensus on US earnings that factors to a drop of simply three % versus pre-COVID-19 ranges in 2019.

“Whereas extra stimulus might present upside dangers, rising COVID instances recommend a extra tepid restoration from right here.”

Folks sporting protecting face masks sit close to the Colosseum in Rome, Italy [File: Guglielmo Mangiapane/Reuters]

There have been some cracks showing in expectations of a V-shaped bounce-back in earnings, with the tempo of upward revisions in world earnings estimates cooling down in current weeks.

Many firms are nonetheless troubled by the pandemic. Coca-Cola Co mentioned final month that it’ll lower 2,200 jobs globally, together with 1,200 within the US, as a result of affect of the virus on the financial system.

Nonetheless, US and European firms had been seen reporting revenue progress of 20.8 % and 38 % respectively for 2021, based on Refinitiv evaluation based mostly on MSCI indexes.

Some US strategists assume consensus forecasts could also be underestimating the anticipated pick-up within the financial system.

Jonathan Golub, chief US fairness strategist and head of quantitative analysis at Credit score Suisse Securities, raised his 2021 targets on the S&P 500 final week, saying in a report that “the seemingly avalanche of pent-up shopper demand can’t be ignored”.

Vaccine roll-outs have been a serious purpose for the rosy outlook.

“There may be widespread hope {that a} COVID-19 vaccine roll-out in 2021 can normalise the underlying actual financial system and enhance earnings, employment and margins,” mentioned Steen Jakobsen, chief funding officer at funding financial institution Saxo.

“The chance is that new mutations of the virus will dilute our try to normalise our society with the first-generation vaccine.”